
Suppliers (Tier 1)
FY, 2024
Critical Suppliers (Non-Tier 1)
FY, 2024
Countries (Patients)
FY, 2024
| Metrics | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|
| Suppliers (Tier 1) | 11K | 10.4K | 9.4K |
| Critical Suppliers (Non-Tier 1) | 3 | 22 | 22 |
| Countries (Patients) | 100 | 100 | 100 |
| MSMEs/Small Producers | 2.9K | 3K | 3K |
| API Production, tonnes | 3.4K | 2.8K | 3.2K |
| Formulation Units Manufactured | 20.7B | 19.5B | 20.1B |
| Manufacturing Sites | 15 | 15 | 15 |
| Critical Suppliers (Tier 1) | 519 | 516 | 498 |
| Research Centers | 7 | 7 | 7 |
| Respiratory Products in Pipeline | 22 | 15 | |
| HCPs Participated in Doctor Education Programs | 15K | 78K | |
| Formulation Units Sold | 29B | 27B | |
| Injectables in Pipeline | 30 | 25 | |
| Patients Reached (Patient Education Programs) | 625K | 1.4M | |
| Oral Solids Manufactured | 19.9B | ||
| Product Portfolio | 1.2K | ||
| Topicals Manufactured | 2M | ||
| Ophthalmic Liquids Manufactured | 1.4M | ||
| Injectables Manufactured | 100K | ||
| Oral Liquids Manufactured | 8.4M | ||
| Nasal Inhalers Manufactured | 566M |
Community
Employees
Environment
Governance
Source:CSRHub